Medicaid paid $1.27 billion more for EpiPen allergic-reaction treatments than it should have from 2006 to 2016, well more than the sum Mylan NV said it agreed to pay to settle allegations, a government watchdog said.
from WSJ.com: US Business http://ift.tt/2rcAhJE
via IFTTT
No comments:
Post a Comment